Skip to content
Home/Companies/Biotech/SVF Vaccines

SVF Vaccines

Biotech·Sweden·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns SVF Vaccines?

SVF Vaccines is a Swedish Biotech company, currently owned by Karolinska Development since 2020.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Karolinska Development
Investor
Karolinska Development
Karolinska Development · 2003 · Life Sciences VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Karolinska Development

Other portfolio companies in the same fund.

BOOST Pharma
Active
BiotechDenmark· 2024
PharmNovo
Active
BiotechSweden· 2022
AnaCardio
Active
BiotechSweden· 2021
Modus Therapeutics
Modus Therapeutics
Active
BiotechSweden· 2011
OssDsign
Active
MedTechSweden· 2011
Biosergen
Active
BiotechSweden· 2004

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns SVF Vaccines?

SVF Vaccines is currently owned by Karolinska Development, through Karolinska Development, since 2020.

When did Karolinska Development acquire SVF Vaccines?

Karolinska Development acquired SVF Vaccines in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue